Garamycin ophthalmic solution enters market

NEW YORK — Fera Pharmaceuticals has launched an ocular bacterial infections treatment.

The company announced the launch of Garamycin (gentamicin sulfate) ophthalmic solution USP, designed to treat such infections as conjunctivitis, keratitis and blepharitis.

Last year, Fera broadened its Garamycin product offerings with the launch of preservative-free Garamycin ophthalmic ointment.

Login or Register to post a comment.